ITM2A and breast carcinoma: Through genome-wide expression analysis, we found that the mRNA level of ITM2A was 7.40-fold down-regulated in breast cancer tissues (n = 1101) compared with that in normal tissues (n = 139) from the TCGA database of breast cancer (Fig. 1a).